UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The p53 network: cellular and systemic DNA damage responses in aging and cancer

Trends in genetics, 2012-03, Vol.28 (3), p.128-136

2012

Volltextzugriff (PDF)

Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response

Nature reviews. Molecular cell biology, 2013-09, Vol.14 (9), p.563-580

2013

Volltextzugriff (PDF)

Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches

Trends in genetics, 2014-08, Vol.30 (8), p.326-339

2014

Volltextzugriff (PDF)

Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes

Nature communications, 2021-04, Vol.12 (1), p.2048-2048, Article 2048

2021

Volltextzugriff (PDF)

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (15), p.4270-4281

2018

Volltextzugriff (PDF)

Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis

Scientific reports, 2021-11, Vol.11 (1), p.22062-22062, Article 22062

2021

Volltextzugriff (PDF)

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer

Scientific reports, 2017-11, Vol.7 (1), p.15511-16, Article 15511

2017

Volltextzugriff (PDF)

p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA Damage

Cancer cell, 2007-02, Vol.11 (2), p.175-189

2007

Volltextzugriff (PDF)

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

Nature communications, 2020-08, Vol.11 (1), p.4124-4124, Article 4124

2020

Volltextzugriff (PDF)

Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression

PloS one, 2015-05, Vol.10 (5), p.e0125745

2015

Volltextzugriff (PDF)

DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization

Molecular cell, 2010-10, Vol.40 (1), p.34-49

2010

Volltextzugriff (PDF)

Data-driven grading of acute graft-versus-host disease

Nature communications, 2023-11, Vol.14 (1), p.7799-17, Article 7799

2023

Volltextzugriff (PDF)

Exploiting synthetic lethal interactions for targeted cancer therapy

Cell cycle (Georgetown, Tex.), 2009-10, Vol.8 (19), p.3112-3119

2009

Volltextzugriff (PDF)

A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo

Cell reports (Cambridge), 2013-11, Vol.5 (4), p.868-877

2013

Volltextzugriff (PDF)

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization

Molecular cancer therapeutics, 2022-05, Vol.21 (5), p.821-830

2022

Volltextzugriff (PDF)

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway

The Journal of cell biology, 2011-05, Vol.193 (4), p.633-642

2011

Volltextzugriff (PDF)

Pericentromeric Satellite III transcripts induce etoposide resistance

Cell death & disease, 2021-05, Vol.12 (6), p.530-15, Article 530

2021

Volltextzugriff (PDF)

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities

Cancer Immunology, Immunotherapy, 2018-11, Vol.67 (11), p.1797-1807

2018

Volltextzugriff (PDF)

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia

Nature communications, 2017-07, Vol.8 (1), p.153-13, Article 153

2017

Volltextzugriff (PDF)

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

European journal of medical research, 2021-06, Vol.26 (1), p.63-63, Article 63

2021

Volltextzugriff (PDF)

Biallelic variants in YRDC cause a developmental disorder with progeroid features

Human genetics, 2021-12, Vol.140 (12), p.1679-1693

2021

Volltextzugriff (PDF)

Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength

Cell, 2008-10, Vol.135 (2), p.343-354

2008

Volltextzugriff (PDF)

The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ

Human molecular genetics, 2012-12, Vol.21 (26), p.5528-5538

2012

Volltextzugriff (PDF)

Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival

Frontiers in immunology, 2021-09, Vol.12, p.694843-694843

2021

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(170)

Publikationsform

Artikel
(187)
Buchkapitel
(12)
Bücher
(3)

Sprache

Englisch
(189)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The p53 network: cellular and systemic DNA damage responses in aging and cancer

Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response

Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches

Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer

A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer

Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer

p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA Damage

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression

DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization

Data-driven grading of acute graft-versus-host disease

Exploiting synthetic lethal interactions for targeted cancer therapy

A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway

Pericentromeric Satellite III transcripts induce etoposide resistance

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

Biallelic variants in YRDC cause a developmental disorder with progeroid features

Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength

The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ

Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival

Suchergebnisse filtern